Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Postoperative Nausea and Vomiting: later-stage trial registry
3 of 11 indexed Postoperative Nausea and Vomiting trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 3 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Postoperative Nausea and Vomiting: 11 US clinical trials tracked, 3 recruiting.
Postoperative Nausea and Vomiting is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Acacia Pharma, running 2 of these trials.
Enrollment posture brief
Registry condition postoperative-nausea-and-vomiting
OPEN 3 | RECR 27% | LATE 4 | EARLY 2 | RANK #1577 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Atherosclerotic Cardiovascular Disease (27% recruiting · 22 trials)
Postoperative Nausea and Vomiting lists 3 open slots (27% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Postoperative Nausea and Vomiting on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Postoperative Nausea and Vomiting is recruiting below its size-band peers.
3 of 11 indexed trials (27.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Postoperative Nausea and Vomiting research.
Acacia Pharma accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Postoperative Nausea and Vomiting enrolment sits around 132 participants.
Median target enrolment is 132 among the 11 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
Postoperative Nausea and Vomiting research is mostly interventional.
8 interventional and 3 observational studies make up this index (72.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
United States Naval Medical Center, Portsmouth
NCT06488001
Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.
University of Pennsylvania
NCT07063979
A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population
Benaroya Research Institute
NCT06585540
Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV)
University of California, San Francisco
NCT00514878
Study of APD421 as PONV Treatment (Prior Prophylaxis)
Acacia Pharma
NCT02646566
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
GlaxoSmithKline
NCT00334152
Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)
Acacia Pharma
NCT00895830
Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children
Baylor College of Medicine
NCT02421952
The Effect of Electroacustimulation on Postoperative Nausea, Vomiting and Pain in Outpatient Plastic Surgery Patients
University of Wisconsin, Madison
NCT00941005
Costs of Postoperative Nausea and Vomiting in Ambulatory Surgery Patients
The Cleveland Clinic
NCT00858949
Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients
Scott and White Hospital & Clinic
NCT00738621
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Postoperative Nausea and Vomiting records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Postoperative Nausea and Vomiting trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Postoperative Nausea and Vomiting page
11 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Postoperative Nausea and Vomiting trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Acacia Pharma sponsors the most Postoperative Nausea and Vomiting trials on record, review their full trial history before evaluating a specific study. See Acacia Pharma's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Postoperative Nausea and Vomiting condition card totals 11 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.